Gilbert R. Gonzales

Prolong Pharmaceuticals LLC develops and manufactures biopharmaceutical products to treat anemias, cancers and their debilitating comorbidities. The firm focuses on sickle cell anemia, diabetic ischemia, and several trauma indications. Its products include SANGUINATE, an oxygen transfer agent to treat anemia and protein therapeutics. The company was founded by Abraham Abuchowski in 2002 and is headquartered in South Plainfield, NJ.

SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France.

The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care.

Radiological Society of North America, Inc. provides health care services through education and research. Its professionals include radiologists, radiation oncologists, medical physicists and allied scientists. The company was founded in 1915 and is headquartered in Oak Brook, IL.

Avon Foundation For Women provides granting services. The non-profit company is based in New York, NY.

German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany.

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Cancer Prevention & Research Institute of Texas provides cancer research and prevention programs and services. It is the state agency mandated to create and expedite innovation in the area of cancer research and in enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer. The company was founded in 2007 and is headquartered in Austin, TX.

Institut Gustave Roussy EURL is a cancer research and treatment center that places innovation at the heart of its services. The private company is based in Chevilly-Larue, France, and has subsidiaries in France. The center has strong partnerships at national and international levels to provide high-value care to all its patients. Patients' rights are protected and guaranteed to ensure their autonomy, respect for their individual liberties, and dignity within the hospital.

Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA.

3bg Advisors & Managers Pvt Ltd. (3bg Advisors) is a venture capital firm founded in 2011 by Neeraj Bhargava. The firm is headquartered in Mumbai, India.

SB/RH Holdings LLC operates as a consumer products company. It manufactures and markets alkaline, zinc carbon, nickel metal hydride rechargeable batteries rechargeable batteries, battery chargers, hearing aid batteries and battery-powered portable lighting products including flashlights and lanterns, and other specialty battery. It also designs, markets and distributes a broad range of branded small household appliances and personal care products, certain hardware, home improvement and plumbing products. The company was founded in 2010 and is headquartered in Middleton, WI.

Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.

Part of MEDIAN Technologies SA, Median Technologies, Inc. provides medical imaging services. The company is based in Burlington, MA. The CEO of the company is Fredrik Bjjorn Brag.

Casita Maria Center for Arts & Education delivers services to the Hispanic youth, families, and seniors of the community it serves. The private company is based in Bronx, NY.

Envisics Ltd. engages in the provision of dynamic holographic platform. Its products include dal image plane; three-lane road coverage; superior image quality, resolution, brightness, and color saturation; and self-correcting. The company was founded by Jamieson Leigh Christmas in 2004 and is headquartered in London, the United Kingdom.

Part of Envisics LLC, Dualitas Ltd. is a British company that engages in developing technologies to deliver holographic and augmented reality products and services. The company is based in London, UK. The company was founded in 2016 by Houman Ashrafian.

Part of Envisics LLC, Envisics Holdings Ltd. functions as an investment holding British company. The company is based in London, UK and was founded in 2016.

Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015.

Z3Partners (Z3Partners) is a venture capital firm founded in 2019 by Gautam Patel. The firm is headquartered in Mumbai, India.

Kashiv Biosciences LLC is a biopharmaceutical company that specializes in developing biosimilars and other complex products. The private company has a pipeline of seven biosimilars and multiple 505 (b) (2) and complex peptide generic products in development. Kashiv is headquartered in Piscataway, NJ, with FDA-approved GMP manufacturing facilities in Illinois and state-of-the-art R&D infrastructure.

Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets.

Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation.